🇦🇪UAE

نقص المخزون والتناقضات في تسجيل المخدرات

2 verified sources

Definition

Federal Decree-Law No. 38 of 2024 introduces mandatory supply chain traceability and enhanced record-keeping for all medical products. Narcotic inventory reconciliation failures create audit trails that expose shrinkage, theft, or diversion. Pharmacies without automated systems cannot account for discrepancies in real time, increasing exposure to EDE investigations and corrective action notices.

Key Findings

  • Financial Impact: 2–5% of narcotic inventory value annually (typical retail pharmacy: 100,000–500,000 AED annual narcotic stock); estimated loss 2,000–25,000 AED per year; detection delays add 20–40 hours/month reconciliation labor at 200 AED/hour
  • Frequency: Continuous (ongoing monthly reconciliation cycles)
  • Root Cause: Manual count procedures; paper-based or unintegrated system records; delayed identification of discrepancies; no real-time alerting for variance

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Retail Pharmacies.

Affected Stakeholders

Pharmacy Technician, Narcotic Custodian, Store Manager, Finance/Audit Team

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

هدر الأدوية منتهية الصلاحية

2-8% of pharmaceutical inventory value; estimated AED 50,000-500,000+ annually per pharmacy network depending on inventory size

عدم الامتثال لمتطلبات تسجيل الأدوية والمراقبة

MOHAP compliance fines estimated AED 10,000-100,000+ per violation; license suspension risk; Corporate Tax penalties for unreconciled inventory discrepancies estimated 2-5% of unreported stock value

أخطاء في قرارات إعادة الترتيب والتنبؤ بالطلب

3-5% revenue loss from preventable stockouts; 2-4% capital waste from overstocking; estimated AED 100,000-500,000 annually for mid-size UAE pharmacy network

تقليص المخزون والسرقة وعدم المراقبة

1-3% inventory shrinkage; estimated AED 75,000-300,000 annually per mid-size pharmacy network; plus potential MOHAP penalties for unaccounted controlled substances (fines AED 50,000+)

خسارة الطاقة الاستيعابية والتأخيرات اليدوية

20-40 hours/month of pharmacy staff time; estimated AED 6,000-15,000 monthly (at AED 150-200/hour fully-loaded labor cost); AED 72,000-180,000 annually per pharmacy location

Manuelle Überwachung kontrollierter Substanzen – Operative Ineffizienz

Estimated capacity loss: 200–350 hours annually per pharmacy × average pharmacist wage (AED 120–180/hour in UAE) = AED 24,000–63,000 annually in unrecovered labor. High-volume pharmacies (100+ controlled Rx/month): AED 40,000–80,000+

Request Deep Analysis

🇦🇪 Be first to access this market's intelligence